SignalXSignalX

HRTX HERON THERAPEUTICS, INC. /DE/

8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical Preparations
HERON THERAPEUTICS, INC. /DE/ Overview

HERON THERAPEUTICS, INC. /DE/ (HRTX) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 financial results released Feb 26, 2026 — details in Exhibit 99.1
  • • Coverage period: three and twelve months ended December 31, 2025

Get deeper insights on HERON THERAPEUTICS, INC. /DE/

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.